JP2005507995A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005507995A5 JP2005507995A5 JP2003530827A JP2003530827A JP2005507995A5 JP 2005507995 A5 JP2005507995 A5 JP 2005507995A5 JP 2003530827 A JP2003530827 A JP 2003530827A JP 2003530827 A JP2003530827 A JP 2003530827A JP 2005507995 A5 JP2005507995 A5 JP 2005507995A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32494801P | 2001-09-27 | 2001-09-27 | |
| PCT/US2002/030611 WO2003027255A2 (en) | 2001-09-27 | 2002-09-27 | Anti-fusion assay |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005507995A JP2005507995A (ja) | 2005-03-24 |
| JP2005507995A5 true JP2005507995A5 (ja) | 2005-12-22 |
Family
ID=23265811
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003530827A Pending JP2005507995A (ja) | 2001-09-27 | 2002-09-27 | 抗抑制アッセイ |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20050208678A1 (ja) |
| EP (1) | EP1438333A4 (ja) |
| JP (1) | JP2005507995A (ja) |
| CA (1) | CA2461853A1 (ja) |
| WO (1) | WO2003027255A2 (ja) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100280268A1 (en) * | 2006-04-06 | 2010-11-04 | Dams Gery Karel Julia | Homogeneous time resolved fluorescence based test system |
| ATE524733T1 (de) * | 2007-07-26 | 2011-09-15 | Tibotec Pharm Ltd | Natives gp41-testverfahren |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6001555A (en) * | 1994-09-23 | 1999-12-14 | The United States Of America As Represented By The Department Of Health And Human Services | Method for identifying and using compounds that inactivate HIV-1 and other retroviruses by attacking highly conserved zinc fingers in the viral nucleocapsid protein |
| US6818740B1 (en) * | 1997-04-17 | 2004-11-16 | Whitehead Institute For Biomedical Research | Inhibitors of HIV membrane fusion |
| US6150088A (en) * | 1997-04-17 | 2000-11-21 | Whitehead Institute For Biomedical Research | Core structure of gp41 from the HIV envelope glycoprotein |
| KR20010099605A (ko) * | 1998-07-30 | 2001-11-09 | 존 프랫 | Ｈｉｖ 막융합 억제제 |
| JP4925540B2 (ja) * | 1999-12-16 | 2012-04-25 | ホワイトヘッド インスチチュート フォアー バイオメディカル リサーチ | ５−ヘリックスタンパク質 |
| EP1399180A4 (en) * | 2000-02-29 | 2004-04-07 | Progenics Pharm Inc | CCR5 SULPHATE PEPTIDES FOR THE TREATMENT OF HIV-1 INFECTION |
| NZ535614A (en) * | 2002-03-11 | 2006-10-27 | Tibotec Pharm Ltd | Small molecule entry inhibitors |
-
2002
- 2002-09-27 WO PCT/US2002/030611 patent/WO2003027255A2/en active Application Filing
- 2002-09-27 JP JP2003530827A patent/JP2005507995A/ja active Pending
- 2002-09-27 US US10/490,716 patent/US20050208678A1/en not_active Abandoned
- 2002-09-27 CA CA002461853A patent/CA2461853A1/en not_active Abandoned
- 2002-09-27 EP EP02783985A patent/EP1438333A4/en not_active Withdrawn